Mutational status may supersede tumor size in predicting the presence of aggressive pathologic features in well differentiated thyroid cancer

Table 3 Simple logistic regression analysis of association between pathological size and presence of BRAF^V600E mutation

	OR (95% CI)
Pathological size (continuous), cm	0.61 (0.45–0.82)
Pathological size 0–1.00 cm, N (%)	2.03 (1.08–3.93)
Pathological size 1.01–1.50 cm, N (%)	1.34 (0.72–2.52)
Pathological size 1.51–2.00 cm, N (%)	0.91 (0.44–1.88)
Pathological size > 2.01 cm, N (%)	0.45 (0.25–0.80)

ISSN: 1916-0216